FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Medtronic Harmony Transcatheter Pulmonary Valve OKd

FDA approves a Medtronic PMA for its Harmony Transcatheter Pulmonary Valve, the first minimally invasive therapy to treat patients with a specific typ...

Medical Devices

At-Home Tests to Advance Due to Covid Experience: FDA

CDRH officials reflecting on Covid-19 experience say at-home diagnostics will accelerate technological advances that benefit routine medical care and ...

Human Drugs

Panel Shoots Down Pfizer Arthritis Drug REMS

An FDA advisory committee votes 19 to 1 that a Pfizer-proposed Risk Evaluation and Mitigation Strategy in its BLA for osteoarthritis drug tanezumab su...

Biologics

FDA Requires Guillain-Barr Warning in Shingrix Labeling

FDA requires Glaxo to add information to the Shingrix labeling on an association between the shingles vaccine and Guillain-Barr Syndrome.

Human Drugs

Arbor Nymalize Suit Looks at FDA Product Withdrawal Reasons

Attorney Sarah Cork describes an Arbor Pharmaceuticals suit challenging an FDA determination that the companys withdrawal of its original Nymalize was...

Human Drugs

Consider Benzedrex Design Changes: FDA

FDA asks for changes to Benzedrex OTC decongestant inhalers to reduce the likelihood of abuse and misuse.

Human Drugs

Alembic Pharmaceuticals Recalls 1 Lot of Telmisartan Tablets

Alembic Pharmaceuticals recalls one lot of telmisartan tablets, USP, 20 mg, packaged in 30-count bottles due to a mislabeling concern.

Biologics

AstraZeneca Covid Vaccine Efficacy Revised to 76%

AstraZeneca revises its Covid-19 clinical trial vaccine efficacy rate from 79% to 76% under a primary analysis after the studys data and safety monito...

Human Drugs

CDER, C-Path Acute Kidney Injury Project

CDER and the Critical Path Institute say they are launching an acute kidney injury project to develop prognostic tools.

Human Drugs

FDA Republishes OTC Monograph Fee Rates

FDA republishes OTC monograph user fees for FY 2021 to exclude some facilities producing hand sanitizer during the pandemic.